Evaluation of cyclodextrin solubilization of drugs

International Journal of Pharmaceutics

Volumn 302, Issue 1-2, 2005, Pages 18-28

  Loftsson, Thorsteinn ^a   Hreinsdóttir, Dagný ^a   Másson, Már ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Complex; Complexation efficiency; Cyclodextrin; Ideal solution; Solubility

Indexed keywords

ACETAZOLAMIDE; ALFAXALONE; ALPRAZOLAM; CALCIPOTRIOL; CARBAMAZEPINE; CINNARIZINE; CLOTRIMAZOLE; CYCLODEXTRIN; CYCLOSPORIN A; DEXAMETHASONE; DEXTROMETHORPHAN; DIETHYLSTILBESTROL; DIFLUNISAL; DIGOXIN; ECONAZOLE; ERGOTAMINE; ESTRADIOL; EXCIPIENT; FINASTERIDE; FLUNITRAZEPAM; FLUOXETINE; HYDROCORTISONE; KETOCONAZOLE; KETOPROFEN; METHAZOLAMIDE; MICONAZOLE; NAPROXEN; OMEPRAZOLE; OXAZEPAM; UNINDEXED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLUBILIZATION; STOICHIOMETRY;

ALGORITHMS; CYCLODEXTRINS; DRUG STABILITY; EXCIPIENTS; KINETICS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SOLUTIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 24344508654     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.05.042     Document Type: Article

References (47)

1. P.O. Anderson J.E. Knoben W.G. Troutman Handbook of Clinical Drug Data ninth ed. 1999 Appelton & Lange Stamford
2. C.A.S. Bergström, K. Luthman, and P. Artursson Accuracy of calculated pH-dependent aqueous drug solubility Eur. J. Pharm. Sci. 22 2004 387 398
3. N. Bodor, and P. Buchwald Theoretical insights into the formation, structure, and energetics of some cyclodextrin complexes J. Incl. Phenom. Macroc. Chem. 44 2002 9 14
4. M.E. Brewster, W.R. Anderson, T. Loftsson, M.-J. Huang, N. Bodor, and E. Pop Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-β-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse J. Pharm. Sci. 84 1995 1154 1159
5. K.A. Connors Population characteristics of cyclodextrin complex stabilities in aqueous solution J. Pharm. Sci. 84 1995 843 848
6. H. Fridriksdóttir, T. Loftsson, J.A. Gudmundsson, G.J. Bjarnason, M. Kjeld, and T. Thorsteinsson Design and in vivo testing of 17β-estradiol-HPβCD sublingual tablets Pharmazie 51 1996 39 42
7. H. Fridriksdóttir, T. Loftsson, and E. Stefánsson Formulation and testing of methazolamide eye drop solutions J. Control. Rel. 44 1997 95 99
8. T. Higuchi, and K.A. Connors Phase-solubility techniques Adv. Anal. Chem. Instrum. 4 1965 117 212
9. K.T. Johnson, G.L. Mosher, and D.O. Thompson Investigation of atypical bi-phasic complexation curves observed when charges cyclodextrins solubilize charges drug compounds AAPS: Annual Meeting & Exposition Baltimore, 7-11 November 2004
10. A.R. Katritzky, D.C. Fara, H. Yang, M. Karelson, T. Suzuki, V.P. Solov'ev, and A. Varnek Quantitative structure-property relationship modeling of β-cyclodextrin complexation free energies J. Chem. Inf. Comput. Sci. 44 2004 529 541
11. W. Kunz, P. Lo Nostro, and B.W. Niham The present state of affairs with Hofmeister effects Curr. Opin. Colloid Interface Sci. 9 2004 1 18
12. C.A. Lipinski Drug-like properties and the cause of poor solubility and poor permeability J. Pharmacol. Toxicol. Meth. 44 2000 235 249
13. T. Loftsson, and N. Bodor Effects of 2-hydroxypropyl-β-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17β-estradiol Acta Pharm. Nord. 1 1989 185 193
14. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 10 1996 1017 1025
15. T. Loftsson, M.E. Brewster, and M. Másson Role of cyclodextrins in improving oral drug delivery Am. J. Drug Deliv. 2 2004 261 275
16. T. Loftsson, H. Fridriksdottir, and B.J. Olafsdottir Solubilization and stabilization of drugs through cyclodextrin complexation Acta Pharm. Nord. 3 1991 215 217
17. T. Loftsson, H. Fridriksdottir, A.M. Sigurdardottir, and H. Ueda The effect of water-soluble polymers on drug-cyclodextrin complexation Int. J. Pharm. 110 1994 169 177
18. T. Loftsson, H. Fridriksdottir, E. Stefansson, S. Thorisdottir, O. Gudmundsson, and T. Sigthorsson Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits J. Pharm. Pharmacol. 46 1994 503 504
19. T. Loftsson, H. Fridriksdottir, S. Thorisdottir, and E. Stefansson The effect of hydroxypropyl methylcellulose on release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations Int. J. Pharm. 104 1994 181 184
20. T. Loftsson, and H. Fridriksdóttir The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin Int. J. Pharm. 163 1998 115 121
21. T. Loftsson, H. Gudmundsdottir, J.F. Sigurjonsdottir, H.H. Sigurdsson, S.D. Sigfusson, M. Masson, and E. Stefansson Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray Int. J. Pharm. 212 2001 29 40
22. T. Loftsson, T.K. Gudmundsdóttir, and H. Fridriksdóttir The influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs Drug Dev. Ind. Pharm. 22 1996 401 405
23. T. Loftsson, A. Magnúsdóttir, M. Másson, and J.F. Sigurjónsdóttir Self-association and cyclodextrin solubilization of drugs J. Pharm. Sci. 91 2002 2307 2316
24. T. Loftsson, K. Matthíasson, and M. Másson The effects of organic salts on the cyclodextrin solubilization of drugs Int. J. Pharm. 262 2003 101 107
25. T. Loftsson, and M. Másson The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs J. Drug Deliv. Sci. Tech. 14 2004 35 43
26. T. Loftsson, M. Másson, and M.E. Brewster Self-association of cyclodextrins and cyclodextrin complexes J. Pharm. Sci. 93 2004 1091 1099
27. T. Loftsson, M. Másson, and J.F. Sigurjónsdóttir Methods to enhance the complexation efficiency of cyclodextrins S.T.P. Pharma Sci. 9 1999 237 242
28. T. Loftsson, Í.B. Össurardóttir, M. Duan, N. Zhao, T. Thorsteinsson, and M. Másson Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: effect of ionization and polymers J. Incl. Phenom. Macroc. Chem. 52 2005 109 117
29. T. Loftsson, B.J. Ólafsdóttir, H. Fridriksdóttir, and S. Jónsdóttir Cyclodextrin complexation of NSAIDS: physicochemical characteristics Eur. J. Pharm. Sci. 1 1993 95 101
30. T. Loftsson, and D.S. Petersen Cyclodextrin solubilization of water-insoluble drugs: calcipotriol and EB-1089 Pharmazie 52 1997 783 786
31. T. Loftsson, and A.M. Sigurdardottir The effect of polyvinypyrrolidone and hydroxylpropyl methylcellulose on HPβCD complexation of hydrocortisone and its permeability through hairless mouse skin Eur. J. Pharm. Sci. 2 1994 297 301
32. T. Loftsson, E. Stefánsson, J.K. Kristinsson, H. Fridriksdóttir, T. Sverrisson, G. Gudmundsdóttir, and S. Thórisdóttir Topically effective acetazolamide eye-drop solution in man Pharm. Sci. 2 1996 277 279
33. A.D. Marcus Complexation incompatibilities Drug Cosmet. Ind. 79 1956 p. 554, 564, pp. 456-457, 560-561
34. A.C. Moffat M.D. Osselton B. Widdop Clarke's Analysis of drugs and poisons 2004 Pharmaceutical Press London
35. K. Okimoto, R.A. Rajewski, K. Uekama, J.A. Jona, and V.J. Stella The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins Pharm. Res. 13 2 1996 256 264
36. R.A. Rajewski, and V.J. Stella Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 85 11 1996 1142 1168
37. V.M. Rao, and V.J. Stella When can cyclodextrins be considered for solubilizing purposes? J. Pharm. Sci. 92 2003 927 932
38. E. Redenti, L. Szente, and J. Szejtli Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications J. Pharm. Sci. 89 2000 1 8
39. E. Redenti, L. Szente, and J. Szejtli Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications J. Pharm. Sci. 90 2001 979 986
40. C.M. Riley J.H. Rytting M.A. Kral Takeru Higuchi, a Memorial Tribute. Equilibria and Thermodynamics vol. 3 1991 Allen Press Lawrence
41. H.J. Roth, K. Eger, and R. Troschütz Pharmaceutical chemistry Drug Analysis 1991 Ellis Horwood Ltd. Chichester
42. R. Schmid Recent advances in the description of the structure of water, the hydrophobic effect, and the like-dissolves-like rule Chem. Month. 132 2001 1295 1326
43. A.M. Sigurdardottir, and T. Loftsson The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin Int. J. Pharm. 126 1995 73 78
44. P. Tomasik, and C.H. Schilling Complexes of starch with organic guests D. Horton Complexes of Starch with Organic Guests Book vol. 53 1998 Academic Press San Diego 345 426
45. S.S. Xantheas Cooperativity and hydrogen bonding network in water clusters Chem. Phys. 258 2000 225 231
46. S.H. Yalkowsky Solubility and Solubilization in Aqueous Media 1999 Am. Chem. Soc. Washington, DC
47. T. Yamakawa, and S. Nishimura Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-β- cyclodextrin J. Control. Rel. 86 2003 101 113